InvestorsHub Logo
Followers 834
Posts 120143
Boards Moderated 17
Alias Born 09/05/2002

Re: rwwine post# 16622

Saturday, 02/11/2017 4:07:03 PM

Saturday, February 11, 2017 4:07:03 PM

Post# of 20689
I agree. There is no legal or regulatory impetus for the FDA to hold up one ANDA in order to approve it simultaneously with other ANDA(s). To the contrary, the FDA's GDUFA regs prioritize the review of the first ANDA for drugs that have no generic competition.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”